CCN5 and breast cancer: The studies have also demonstrated that theupregulated ER-α is functionally active in both normal and transformed cells.Mechanistically, based on current and our previous work on BC cells,28 CCN5 interacts with integrin α6β1 tosuppress the PI3K/Akt-signaling which then activates FOXO3a.